Journal Highlight : Clinical Biomarkers
The journal welcomes scholarly contributions related to the discovery, validation, and clinical application of biomarkers used in disease diagnosis, prognosis, therapeutic monitoring, and personalized medicine. This section focuses on research that advances biomarker science and supports precision-based clinical decision-making across diverse biomedical and healthcare disciplines.
The journal encourages submissions in areas including Diagnostic Biomarkers, Prognostic and Predictive Biomarkers, Molecular and Genetic Biomarkers, Protein and Metabolite Biomarkers, Circulating Biomarkers, Immunological Biomarkers, Cancer Biomarkers, and Biomarkers in Infectious, Metabolic, Neurological, and Cardiovascular Diseases. Research related to Liquid Biopsy Biomarkers, Multi-Omics Biomarker Discovery, Companion Diagnostics, Biomarker-Based Therapeutic Stratification, and Precision Medicine Applications is also welcomed.
Submissions focusing on Biomarker Validation and Clinical Utility, Disease Monitoring and Treatment Response Assessment, AI and Bioinformatics in Biomarker Research, Translational Biomarker Development, Point-of-Care Biomarker Technologies, Early Disease Detection, Biostatistics and Predictive Modeling, and Personalized Healthcare Approaches are encouraged. The journal also welcomes studies investigating biomarker-guided diagnostics and therapies, disease progression markers, therapeutic resistance indicators, and integrative clinical biomarker platforms.
Accepted manuscript types include Original Research Articles, Systematic Reviews, Meta-Analyses, Clinical and Experimental Studies, Diagnostic Evaluation Studies, Translational Research Articles, Methodology and Technical Reports, and Case-Based Clinical Studies that contribute to advancements in clinical biomarker research.
Through this focus area, the journal aims to support research that improves biomarker-driven healthcare, enhances diagnostic and prognostic precision, advances personalized and translational medicine, and contributes to innovation in biomedical and molecular medicine worldwide.
